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2Abstract
Aim: To establish whether children with type 1 diabetes (T1D) should be routinely screened for
celiac disease.
Methods: Clinical and histological data at celiac disease diagnosis and adherence and response to
the gluten-free diet on follow-up were compared between 22 children detected by serological
screening during T1D surveillance and 498 children diagnosed because of clinical suspicion.
Results: T1D children suffered less from decreased growth (14.3% vs 40.6%, p=0.016) and clinical
symptoms (44.5% vs 98.6%, p<0.001) at celiac disease diagnosis than those detected on clinical
grounds. There was no difference between the groups at diagnosis in age (median 7.3 vs 7.9 years,
p=0.903), gender (girls 55.0% vs 64.0%, p=0.353), presence of anemia (20.0% vs 21.3%, p=0.886),
endomysial antibody titers (median 1:500 vs 1:500, p=0.789) and severity of small-bowel mucosal
atrophy (p=0.104). Moreover, the groups showed equal adherence (87.5% vs 85.7%, p=0.086) and
clinical response (94.7% vs 96.2%, p=0.542) to the gluten-free diet after a median of 13 months´
follow-up.
Conclusion: Celiac patients detected during T1D surveillance had signs of malabsorption and
advanced mucosal damage similarly to those diagnosed on clinical basis. Further, the T1D children
often suffered from unrecognized gluten-dependent symptoms and showed excellent adherence
and response to the gluten-free diet.
Keywords: Celiac disease, Diabetes, Children, Screening
3Key Notes:
· Children whose celiac disease was found in regular type 1 diabetes surveillance were
comparable to clinically diagnosed celiac patients in terms of serology and histology.
·  These screen-detected patients had also often had unrecognized celiac disease symptoms
before diagnosis, and showed excellent adherence and response to the gluten-free diet
· The results support active screening for celiac disease in children with type 1 diabetes
4Introduction
Over the past few decades we have witnessed a major increase in the clinical prevalence of celiac
disease 1. One reason for this rapid change has been the recognition of specific at-risk groups, of
which type 1 diabetes (T1D) is one of the best known2. Due to the high concurrence of the two
diseases many recent guidelines recommend systematic screening for celiac disease in T1D.
Nevertheless, screening on a regular basis remains controversial, since these children are often
apparently asymptomatic 3-7. This, together with the fact that these subjects already have another
chronic disease requiring continuous care, is considered to predispose to poor adherence to the
demanding and socially restrictive gluten-free diet. Accordingly, some previous studies have
shown dietary adherence as low as 25-30% in T1D patients with celiac disease 8,9. It might also be
argued that early diagnosis is not necessary, since T1D children may have less severe intestinal
damage and thus a lower risk of celiac disease-associated complications 10. These unsolved issues
have led to substantial variation in the implementation of the current diagnostic guidelines and,
instead of systematic screening, many clinicians advocate a more personalized and symptom-based
approach to celiac disease in T1D 11,12. However, previous studies have focused mainly on the
effects of double-diagnosis in T1D and comparison has not been made between patients with celiac
disease only and patients with celiac disease and T1D. 3,5-7,13.
In Finland, the incidence of both celiac disease and T1D is among the highest in the
world, and annual screening for celiac disease in T1D children has consequently been carried out
routinely since the turn of the century. This provided as with an excellent opportunity to compare
clinical and histological characteristics and dietary adherence between celiac children diagnosed
due to previous T1D and those found because of clinical suspicion.
Materials and methods
5Patients and data collection
The study was conducted at the Center for Child Health Research in the University of Tampere and
Tampere University Hospital. The cohort comprised 520 children with a biopsy-proven celiac
disease selected from our regularly updated research database. Patient data were assembled from
the medical reports and, if inadequate, complemented with personal interviews conducted by a
study nurse with expertise in celiac disease. Besides children detected in the clinic or due to
screening of groups at risk of the disease, the database also includes children with asymptomatic
celiac disease detected in prospective screening studies. These children screened for reasons other
than T1D were excluded from the present study, as well as any children with unclear celiac disease
diagnosis.
Clinical data, celiac disease serology and other laboratory values, and severity of
histological damage were collected on all patients at the time of celiac disease diagnosis. Further,
adherence and clinical and serological response to a gluten-free diet were documented. After data
collection the study cohort was divided into two groups based on diagnostic approach as follows:
1. Children diagnosed with celiac disease during regular T1D surveillance (T1D group) and 2.
Children diagnosed due to clinical suspicion of celiac disease (clinical diagnosis group). Altogether
42 of the study subjects had concomitant celiac disease and T1D. Of these, 22 were diagnosed with
celiac disease during annual serological surveillance for T1D and comprised the T1D group (n =
22). The remaining 20 children with diabetes were first diagnosed with celiac disease due to clinical
suspicion and developed T1D only later. Because the celiac disease diagnosis was symptom-based
and reached prior to the T1D diagnosis, these patients were included in the control group (n=498).
The study protocol and collection of medical reports were approved by the Pediatric
Clinic  of  Tampere  University  Hospital  and  the  Ethics  Committee  of  the  Pirkanmaa  Hospital
6District. All children and/or their parents gave written informed consent to possible personal
interviews.
Data analyses
Clinical evaluation
Severity of symptoms at diagnosis was classified into four groups: 1. no symptoms, 2. mild
symptoms (occasionally disturbing gastrointestinal or extra-intestinal symptoms), 3. moderate
symptoms (a combination of symptoms or more distracting or frequent symptoms) and 4. severe
symptoms (continuous symptoms significantly disturbing daily life). Poor growth was defined as
a significant deceleration of growth compared with the nationally standardized reference rate for
age and sex, or lower height than that expected based on the mean parental heights 14,15. Also the
possible presence of other chronic conditions such as selective IgA deficiency, autoimmune
thyroidal disease and trisomy 21, as well as a family history of celiac disease, were recorded.
Celiac disease serology and laboratory values
Serum endomysial antibodies (EmA) were assessed at the celiac disease research center by an
indirect immunofluorescence method using human umbilical cord as a substrate. A dilution of 1:
≥5 for EmA is considered positive, and positive sera is further diluted 1:50, 1:100, 1:200, 1:500,
1:1000, 1:2000 and 1:4000. Transglutaminase 2 antibodies have also been measured routinely in
our hospital  from the early 2000s,  but by reason of the diversity of assays and reference values
results are not directly comparable. Serum hemoglobin (g/l) and mean corpuscular volume (fl)
values at the time of celiac disease diagnosis were collected from all patients. Anemia at diagnosis
was defined as a hemoglobin value below the age- and sex-matched reference in the local hospital
laboratory. Due to the known increased risk of autoimmune thyroidal disease in children with celiac
7disease and T1D, also serum thyroid stimulating hormone (TSH, mU/l) values were collected when
available.
Small-bowel mucosal morphology
Small-bowel mucosal morphology was assessed by hospital pathologists from a minimum of four
biopsies taken from the distal duodenum upon gastrointestinal endoscopy. In 2012 and onwards, at
least  2-3  biopsies  have  also  been  routinely  taken  from  the  duodenal  bulb.  The  celiac  disease
diagnosis is based on the demonstration of villous atrophy with crypt hyperplasia (Marsh III) in
well-oriented biopsy specimens. The degree of the mucosal lesion is further categorized as partial
(PVA), subtotal (SVA) and total (TVA) villous atrophy. This well-established classification
corresponds roughly to Marsh-Oberhuber scores IIIa, IIIb and IIIc.
Dietary adherence and response to treatment
All children with celiac disease were referred to a dietician after the diagnosis for personal dietary
guidance. Adherence to the prescribed gluten-free diet was routinely assessed at follow-up visits
and grouped into three classes: 1. children who adhered to a strict diet, 2. children with occasional
lapses (minor inadvertent gluten exposure less than once a month) and 3. non-compliant children
(one or more lapses a month). Good clinical response to the diet was defined as disappearance of
clinical symptoms, negative seroconversion or a marked decrease (diet less than 1 year) in celiac
autoantibodies and improvement of possible abnormal laboratory values and poor growth.
Statistics
Quantitative data are reported as medians with quartiles. Qualitative and categorical variables are
expressed as percentages. The number of patients with available data on each specific variable is
8reported in the tables. Normally distributed variables were compared by Student´s t-test and skewed
variables by Mann-Whitney U test. Cross-tabulation with χ2-test was used to detect differences in
categorical variables. A P value <0.05 was considered significant in all analyses. Analyses were
made on SPSS statistical software package (version 22, IBM Corp., Armonk, NY).
Results
The median  age  in  the  whole  study  cohort  (n  =  520)  was  7.8  years  and  63.8% were  girls.  The
median age in the T1D group (n=22) was 7.3 years and 55% were girls, while the corresponding
figures in the clinical suspicion group (n=498) were 7.9 years and 64%. In clinically-detected cases,
61.3% had gastrointestinal symptoms and 29.5% extra-intestinal manifestations as the main
presentation at diagnosis. Although all patients in the T1D group were diagnosed in diabetes
surveillance, 55.0% of them reported unrecognized clinical symptoms or signs at celiac disease
diagnosis (Table 1). However, these were less severe than in the clinically diagnosed patients (Fig.
1A). There was no significant difference between the study groups in the severity of small-bowel
mucosal atrophy at celiac disease diagnosis (Fig. 1B). Of note, also half of those in the T1D group
already had subtotal or total villous atrophy.
The screening-detected T1D children suffered less from poor growth at diagnosis than
those in the clinical suspicion group (Table 2). There were also trends towards a lower prevalence
of celiac disease in the family and a higher prevalence of thyroidal disease and trisomy 21 in the
T1D group (Table 2), whereas diagnosis of celiac disease in toddlers was more common among
the clinically detected children (Fig. 1C), the differences being however not significant. No other
significant difference between the groups was demonstrated in any of the other clinical, serological
and laboratory parameters (Tables 2 and 3).
9Patients in both groups showed equal adherence to the gluten-free diet (Fig. 1D). In the
T1D group, one child had occasional and one frequent dietary lapses. In the clinical suspicion group
14.0% of the children had occasional lapses, while again only one reported frequent gluten
consumption. Response to dietary treatment was also comparable, as 94.7% of the T1D patients
and 96.2% of clinically detected children reported symptom relief and showed a significant
reduction in celiac autoantibodies while on the diet (p=0.542). In a separate subgroup analysis of
the 20 diabetic children included in the clinical suspicion group (celiac disease diagnosed prior to
T1D on clinical basis), 70.0% were on a strict diet and 30.0% had occasional lapses. Furthermore,
91.0 % were found to evince good clinical and serological response to the dietary treatment.
Discussion
Our results demonstrate that children diagnosed with celiac disease in the course of T1D
surveillance do not differ in most of their clinical, serological and histological parameters from
those found on clinical basis. In addition, a substantial proportion of these screening-detected
children had unrecognized clinical symptoms, and there was no difference between these two
groups in terms of adherence or response to diet. Our findings thus support the view that children
with T1D would benefit from regular serological screening for celiac disease.
Despite the different diagnostic approach, almost half of the T1D children reported
symptoms at celiac disease diagnosis, and the beneficial dietary response further substantiates the
gluten dependency of these symptoms. This is in line with studies carried out in patients detected
by other types of at-risk group screenings, for example first-degree relatives of celiac disease
patients 10,16,17, and demonstrates that in fact these individuals very often are not asymptomatic but
only unrecognized. The prevalence of reported symptoms in patients with concomitant celiac
disease and T1D has varied from zero to 85% depending on study design and definition of
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symptoms 3,4,6,7,13,18. It is true that here and also in some previous studies the celiac symptoms in
T1D children have been mostly mild 4,19, but it should be realized that even these can cause a
substantial burden and reduce the quality of life in the long term. In fact, as patients cannot compare
their  daily  discomfort  with  that  of  others,  they  often  accept  it  as  an  inevitable  part  of  life  and
recognize it as a consequence of untreated celiac disease only afterwards on a gluten-free diet 10.
The wide spectrum and unspecific nature of the symptoms constitutes a significant diagnostic
challenge to physicians in daily practice, and further supports active screening for celiac disease in
T1D patients.
Approximately half of the children in the T1D group here already evinced subtotal or
total villous atrophy at celiac disease diagnosis. This is in accord with the few previous studies
addressing this topic, which have also found severe atrophy to be common among celiac patients
with concomitant diabetes 6,7. Furthermore, we found no difference between the groups in serum
EmA titers at diagnosis. Together these findings demonstrate that, in spite of an often seemingly
mild clinical presentation, even screen-detected T1D patients may already have a well-advanced
histological and serological disease. It is important to realize that ongoing mucosal damage may
predispose unrecognized celiac patients to excessive use of medication and healthcare services 20,21
and to serious long-term complications 22. Accordingly, several of the T1D children here already
had anemia and poor growth at celiac disease diagnosis. Similar results have previously been
reported by Tsouka and colleagues 23.  It  is  thus  evident  that  that  these  patients  are  at  risk  of
progressing towards an even more severe disease if not diagnosed and placed on dietary treatment.
This issue is of particular importance in T1D children, since it is known that concomitant diabetes
further predisposes celiac disease patients to complicated disease 24. In general, a delay in diagnosis
could lead to various consequences of untreated celiac disease 25,26, and screening has recently been
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proved to constitute a significant protective factor against delay and the subsequent unnecessary
burden of the disease 25.
A necessary prerequisite for active screening for any disease is that the patient adapts
to treatment. Thus, one finding of particular importance here was the equal adherence to the gluten-
free diet regardless of the diagnostic approach. The high self-reported compliance was further
confirmed by the excellent clinical and serological response to the diet. By reason of different study
designs it is difficult to compare our study with previous works. For instance, adherence has been
estimated using a diversity of serological or histological criteria, patients might have switched from
a regular to a gluten-free diet in the course of the study 6, 27, or non-compliant subjects might have
been excluded. Notwithstanding these discrepancies, at least one previous study has found
compliance in T1D children to be comparable with our figures 28. Moreover, our results are in line
with those of a few recent studies conducted in patients screened for celiac disease for reasons other
than preceding T1D 28,29. One factor promoting good adherence in could be the parents´ desire to
optimize their child’s health by treating the disease as well as possible, and the frequent follow-up
of T1D probably lends further support. In spite of the good results here, we recognize that daily
motivation to adherence can be challenging, particularly in asymptomatic individuals with another
burdensome disease 30.  In  our  opinion,  however,  the  families  should  at  least  be  aware  of  the
presence of untreated celiac disease and the potential associated complications, and consider
whether the diet should be started.
Major limitations of the study were the retrospective design and the limited number of
children with concomitant T1D and celiac disease. This latter, however, is a consequence of the
strict inclusion criteria, as we accepted only children screened in routine surveillance for the T1D
group, while the other 20 diabetics in question were placed in the control group, since their diabetes
was found subsequent to the celiac diagnosis. Another limitation is that we did not investigate the
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effect of the gluten-free diet on the metabolic control of T1D, but based on previous evidence, a
well-designed diet may even help to maintain a good glucose balance 7. It must also be borne in
mind that all Finnish children with celiac disease receive monthly financial compensation and the
disease is well-known among physicians. Further, observance of a gluten-free diet is relatively easy
owing to the good availability of appropriate products in groceries and restaurants. This might not
be the case in every country, but we demonstrated that at least in a supportive environment it is
possible to achieve excellent dietary adherence in screen-detected celiac patients with concomitant
T1D.
To conclude, we showed that the presentation of celiac disease is largely comparable
in children found by regular screening during T1D follow-up visits and those diagnosed because
of clinical suspicion. In particular, physicians should acknowledge that many T1D children may
suffer from unrecognized celiac disease symptoms and have well-advanced villous atrophy with a
subsequent increased risk of long-term complications. The excellent adherence and response to the
dietary treatment further advocates active screening for celiac disease in children with T1D.
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Figure legend
Figure 1. Severity of symptoms (A), degree of small-bowel mucosal atrophy (B), age distribution
(C),  and adherence to the gluten-free diet (D) at celiac disease diagnosis in 520 children
diagnosed in the course of regular type 1 diabetes surveillance or due to clinical suspicion
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